Literature DB >> 922705

Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas.

T H Corbett, D P Griswold, B J Roberts, J C Peckham, F M Schabel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 922705     DOI： 10.1002/1097-0142(197711)40:5+<2660::aid-cncr2820400940>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  47 in total

1.  Activity of batracylin (NSC-320846) against solid tumors of mice.

Authors:  P Mucci-LoRusso; L Polin; M C Bissery; F Valeriote; J Plowman; G D Luk; T H Corbett
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

2.  Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours.

Authors:  Johanne Seguin; Céline Nicolazzi; Nathalie Mignet; Daniel Scherman; Guy G Chabot
Journal:  Tumour Biol       Date:  2012-06-07

3.  Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.

Authors:  Kimberly R Jordan; Rachel H McMahan; Jason Z Oh; Matthew R Pipeling; Drew M Pardoll; Ross M Kedl; John W Kappler; Jill E Slansky
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

4.  Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate.

Authors:  T H Corbett; P LoRusso; L Demchick; C Simpson; S Pugh; K White; J Kushner; L Polin; J Meyer; J Czarnecki; L Heilbrun; J P Horwitz; J L Gross; C H Behrens; B A Harrison; R J McRipley; G Trainor
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

5.  Discrepancy between cytotoxicity and DNA interstrand crosslinking of carboplatin and cisplatin in vivo.

Authors:  W DeNeve; F Valeriote; E Tapazoglou; C Everett; A Khatana; T Corbett
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

6.  Comparative efficacy of DMP 840 against mouse and human solid tumor models.

Authors:  P LoRusso; L Demchik; M Dan; L Polin; J L Gross; T H Corbett
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

7.  Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.

Authors:  Rachel H McMahan; Jennifer A McWilliams; Kimberly R Jordan; Steven W Dow; Darcy B Wilson; Jill E Slansky
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

8.  Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model.

Authors:  Katherine A Waugh; Sonia M Leach; Brandon L Moore; Tullia C Bruno; Jonathan D Buhrman; Jill E Slansky
Journal:  J Immunol       Date:  2016-07-01       Impact factor: 5.422

Review 9.  5-Fluorouracil containing combinations in murine tumor systems.

Authors:  T H Corbett; M C Bissery; P Mucci-LoRusso; L Polin
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

10.  Biodistribution Analysis of NIR-Labeled Nanogels Using in Vivo FMT Imaging in Triple Negative Human Mammary Carcinoma Models.

Authors:  Mallory R Gordon; Jiaming Zhuang; Judy Ventura; Longyu Li; Kishore Raghupathi; S Thayumanavan
Journal:  Mol Pharm       Date:  2018-02-12       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.